関連する実験動画
Updated: Jun 22, 2026

08:05
Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
AMP活性化タンパク質キナーゼの自己抑制メカニズムに関する構造的洞察
Lei Chen1, Zhi-Hao Jiao, Li-Sha Zheng
1MOE Key Laboratory of Bioinformatics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China.
Nature
|May 29, 2009
まとめ
AMP活性化タンパク質キナーゼ (AMPK) の活動は,AMP結合によって調節される. 構造と生化学の研究は,自己抑制ドメイン (AID) がAMPKを阻害し,AMP結合がAMPを活性化する方法を示しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 細胞の代謝について
背景:
- AMP活性化タンパク質キナーゼ (AMPK) は,ATP/AMP比を感知することによって,細胞のエネルギーホメオスタシスを調節する.
- AMPKは細胞の成長,増殖,および極性において重要な役割を果たし,代謝疾患および癌の主要な薬剤標的となっています.
- AMPの結合がAMPKの活性を調節する正確なメカニズムは,未だに曖昧である.
研究 の 目的:
- AMPによるAMPK自己抑制と活性化の構造的基礎を解明する.
- 自身阻害ドメイン (AID) がキナーゼ活性を調節する役割を調査する.
- AMPKの活性化に伴う形状の変化を理解する.
主な方法:
- X線結晶学を用いて,非リン酸化AMPKアルファサブユニット断片 (KD-AID) とリン酸化キナーゼ領域 (Snf1-pKD) の構造を決定した.
- バイオケミカルアッセイ (in vitro運動研究を含む) を実施し,キナーゼ活性と変異の影響を評価した.
- 構造分析は,キナーゼ領域と自己抑制領域の相互作用を解釈するために使用されました.
主要な成果:
- 自動阻害ドメイン (AID) はキナーゼドメインのヒンドル領域に結合し,ヘリックスαCを抑制し,キナーゼ活性が著しく低下します.
- KD-AIDインターフェースの破壊は,自己抑制を廃止し,AMPK変異体がAMP濃度の変化に反応しないようにしました.
- AMPは,アロステリックメカニズムを通じて,そしてデフォスフォリレーションを阻害することによって,AMPKを活性化することが示されました.
結論:
- この研究は,AIDによって媒介されるAMPK自己抑制の主要なメカニズムを明らかにしています.
- AMPによるAMPK活性化のためのコンフォームスイッチモデルが提案されており,これは自己抑制の解放を含む.
- これらの発見は,AMPKの調節と潜在的な治療戦略に関する重要な洞察を提供します.
関連する概念動画
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

